Literature DB >> 11033461

Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

A M Tokés1, S Paku, S Tóth, E Paál, J Kulka, J Tóth, A Telekes.   

Abstract

Tenascin is generally classified as an anti-adhesive protein. Many cells do not adhere to tenascin or if they adhere they do not spread. In this study we analysed the stromal expression of tenascin-C in primary, second primary and recurrent breast carcinomas and the ability of tenascin-C to stimulate the focal adhesion plaques in MDA-MB-435 breast carcinoma cell line. To assess the tenascin-C expression formalin-fixed, paraffin-embedded specimens of 20 specially selected breast carcinomas and their recurrences (14) or a second primary breast cancer of the same patient (6) were examined with immunohistochemical methods. We also studied the effect of tenascin-C on focal adhesion plaques added to MDA-MB-435 breast carcinoma cell line. During a median 2,9-year patient follow up 14 local recurrences and 6-second primary breast carcinomas developed in the 20 patients. In 3 cases a second recurrence occurred. The presence of tenascin in tumor cells, in the proliferating and some normal ducts, near to the tumor cell nests, in the stroma and in ductal carcinoma in situ component of the invasive carcinoma may suggest the role of tenascin played in tumor cell migration. Soluble tenascin added to the cell culture had minimal or no effect on focal adhesion plaques. Tenascin only seems not to be of prognostic value in predicting the local recurrence of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033461     DOI: 10.1007/bf03032374

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  36 in total

Review 1.  Anti-adhesive molecules of the extracellular matrix.

Authors:  R Chiquet-Ehrismann
Journal:  Curr Opin Cell Biol       Date:  1991-10       Impact factor: 8.382

Review 2.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

3.  Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.

Authors:  A Vacca; D Ribatti; M Fanelli; F Costantino; B Nico; R Di Stefano; G Serio; F Dammacco
Journal:  Leuk Lymphoma       Date:  1996-08

4.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.

Authors:  R Chiquet-Ehrismann; P Kalla; C A Pearson
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

5.  The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice.

Authors:  U M Wewer; L M Shaw; R Albrechtsen; A M Mercurio
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins.

Authors:  G Chi-Rosso; P J Gotwals; J Yang; L Ling; K Jiang; B Chao; D P Baker; L C Burkly; S E Fawell; V E Koteliansky
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

7.  Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.

Authors:  P L Jones; J Crack; M Rabinovitch
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

8.  Tenascin mediates cell attachment through an RGD-dependent receptor.

Authors:  M A Bourdon; E Ruoslahti
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

9.  Site-restricted expression of cytotactin during development of the chicken embryo.

Authors:  K L Crossin; S Hoffman; M Grumet; J P Thiery; G M Edelman
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

10.  Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

Authors:  T Jahkola; T Toivonen; I Virtanen; K von Smitten; S Nordling; K von Boguslawski; C Haglund; H Nevanlinna; C Blomqvist
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  1 in total

1.  Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.

Authors:  A Brunner; C Mayerl; A Tzankov; I Verdorfer; I Tschörner; H Rogatsch; G Mikuz
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.